Choice Switching and Autism
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04631432|
Recruitment Status : Recruiting
First Posted : November 17, 2020
Last Update Posted : April 1, 2021
|Condition or disease||Intervention/treatment|
|Autism Spectrum Disorder (ASD)||Diagnostic Test: Pre-screening Behavioral: Task session|
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Choice Switching and Autism|
|Actual Study Start Date :||January 1, 2021|
|Estimated Primary Completion Date :||October 2021|
|Estimated Study Completion Date :||October 2021|
All participants will complete the same protocol
Diagnostic Test: Pre-screening
Document upload of Autism diagnosis certificate. Participants can request to show their certificate via a Zoom meeting with the researcher instead of uploading it.
Behavioral: Task session
The Iowa Gambling task- four decks of cards on the computer screen. Each card yields a reward, but might also yield a loss. In each trial, the participant selects a card. Consequently, the card is exposed, displaying the gain and the loss for that trial. Through contingent feedback, participants are expected to learn that some deck are better than others.The task will include 120 trials.
Block of trials without feedback- four decks of cards on the computer screen. Each card yields a reward, but might also yield a loss. In each trial, the participant selects a card. Consequently, the card is exposed, but the gain and the loss for that trial are not displayed. The task will include 30 trials.
Social Responsiveness Scale, 2nd Edition (SRS-2; adult-self report):(Constantino & Gruber, 2012) The brief autism quotient scale:(AQ10; Baron-Cohen et al., 2001) Brief intelligence test (Similarities-MAB + Raven Set 1)
- Mean run size [ Time Frame: Through study completion, an average of 1 year ]Number of consecutive selections from the same deck (across trials and in different blocks).
- Advantageous selections [ Time Frame: Through study completion, an average of 1 year ]Percentage of advantageous selections(across trials and in different blocks).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04631432
|Contact: Eldad Yechiam, Professoremail@example.com|
|Technion, Israel Institute of Technology||Recruiting|
|Contact: Eldad Yechiam, PhD 972-4-8294420 firstname.lastname@example.org|
|Study Director:||Dana Zeif, MSc||Technion, Israel Institute of Technology|
|Study Director:||Ofir Yakobi, PhD||University of Waterloo|
|Principal Investigator:||Eldad Yechaim, Professor||Technion, Israel Institute of Technology|